DoubleRainbow Biosciences

Executive Summary

DoubleRainbow Biosciences is a synthetic biology company based in San Diego, founded in 2016, that leverages natural evolution and bioengineering to produce sustainable active pharmaceutical ingredients (APIs) and consumer health compounds. The company's proprietary enzyme modification platform enables the creation of durable, environmentally friendly supply chains for medicines and ingredients, addressing critical challenges in pharmaceutical manufacturing and natural resource conservation. By harnessing biological systems, DoubleRainbow aims to reduce the environmental footprint of drug production while ensuring reliable access to essential compounds. With a focus on sustainability and human health, DoubleRainbow operates at the intersection of biotechnology and green chemistry. The company's approach involves engineering enzymes to catalyze complex chemical reactions more efficiently than traditional methods, potentially lowering costs and waste. While still in the development stage, DoubleRainbow's platform holds promise for transforming how APIs and high-value ingredients are sourced, offering a compelling alternative to petrochemical-based synthesis or extraction from endangered species. The company's long-term vision aligns with global trends toward sustainable manufacturing and circular economy principles.

Upcoming Catalysts (preview)

• Q4 2026Series A Funding Round70% success
• Q2 2027First Strategic Partnership with Pharma or Nutraceutical Company60% success
• Q3 2026Proof-of-Concept Data for Lead API Program75% success